Kenton Company Profile
✉ Email this page to a colleague
What is the competitive landscape for KENTON, and what generic and branded alternatives to KENTON drugs are available?
KENTON has five approved drugs.
Drugs and US Patents for Kenton
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kenton | REPAGLINIDE | repaglinide | TABLET;ORAL | 091517-002 | Apr 24, 2015 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Kenton | REPAGLINIDE | repaglinide | TABLET;ORAL | 091517-003 | Apr 24, 2015 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Kenton | ANASTROZOLE | anastrozole | TABLET;ORAL | 078944-001 | Jun 28, 2010 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Kenton | SELEGILINE HYDROCHLORIDE | selegiline hydrochloride | TABLET;ORAL | 074912-001 | Apr 30, 1998 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Kenton | REPAGLINIDE | repaglinide | TABLET;ORAL | 091517-001 | Apr 24, 2015 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Kenton | RILUZOLE | riluzole | TABLET;ORAL | 206045-001 | Dec 9, 2019 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Kenton | CYPROHEPTADINE HYDROCHLORIDE | cyproheptadine hydrochloride | TABLET;ORAL | 040644-001 | May 30, 2006 | AA | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.